1. Home
  2. OLED vs BIO Comparison

OLED vs BIO Comparison

Compare OLED & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

OLED

Universal Display Corporation

HOLD

Current Price

$120.02

Market Cap

5.7B

Sector

Technology

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$322.33

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLED
BIO
Founded
1985
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.7B
8.7B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
OLED
BIO
Price
$120.02
$322.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$177.60
$358.50
AVG Volume (30 Days)
498.6K
184.0K
Earning Date
02-19-2026
02-12-2026
Dividend Yield
1.50%
N/A
EPS Growth
N/A
N/A
EPS
4.64
N/A
Revenue
$639,977,000.00
$2,557,500,000.00
Revenue This Year
$2.50
$1.62
Revenue Next Year
$10.90
$2.26
P/E Ratio
$25.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$103.70
$211.43
52 Week High
$164.29
$373.69

Technical Indicators

Market Signals
Indicator
OLED
BIO
Relative Strength Index (RSI) 45.34 58.55
Support Level $119.42 $316.57
Resistance Level $126.85 $328.56
Average True Range (ATR) 3.22 8.27
MACD 0.17 1.43
Stochastic Oscillator 25.20 78.70

Price Performance

Historical Comparison
OLED
BIO

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: